Modeling prognosis for patients with malignant astrocytic gliomas: Quantifying the expression of multiple genetic markers and clinical variables
Open Access
- 1 October 2005
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 7 (4) , 485-494
- https://doi.org/10.1215/s1152851704000730
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell PopulationCancer Research, 2004
- Gene expression profiles of pancreatic cancer and stromal desmoplasiaOncogene, 2001
- Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTENOncogene, 2001
- Comparative genetic patterns of glioblastoma multiforme: Potential diagnostic tool for tumor classificationNeuro-Oncology, 2000
- Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomasOncogene, 1998
- p53 protein and epidermal growth factor receptor expression in human astrocytomasJournal of Neuro-Oncology, 1995
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- Subsets of Glioblastoma Multiforme Defined by Molecular Genetic AnalysisBrain Pathology, 1993
- Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo‐astrocytomasGenes, Chromosomes and Cancer, 1992
- Loss of heterozygosity for 10q loci in human gliomasGenes, Chromosomes and Cancer, 1992